Biote Corp. BTMD US — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Biote Corp. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Biote Corp.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biote Corp.'s us — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biote Corp.'s US — revenue?
- Biote Corp. (BTMD) reported US — revenue of $44.7M in Q1 2026.
- How has Biote Corp.'s US — revenue changed year-over-year?
- Biote Corp.'s US — revenue decreased by 8.2% year-over-year, from $48.7M to $44.7M.
- What is the long-term trend for Biote Corp.'s US — revenue?
- Over 2 years (2023 to 2025), Biote Corp.'s US — revenue has grown at a 1.7% compound annual growth rate (CAGR), from $184.6M to $191.1M.
- What does US — revenue mean?
- This metric represents the total gross revenue generated from the company's core business operations within the United States, specifically excluding any assessed taxes collected from customers. It reflects the primary income stream derived from providing practice-building services, hormone optimization components, and support programs to certified practitioners. This figure serves as a key indicator of the company's market penetration and the scale of its service adoption within its primary geographic market.